Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Methamphetamine and AIDS: 1HMRS studies in a feline model of human disease.

Cloak CC, Chang L, Ernst T, Barr MC, Huitron-Resendiz S, Sanchez-Alavez M, Phillips TR, Henriksen S.

J Neuroimmunol. 2004 Feb;147(1-2):16-20.

PMID:
14741420
2.

Neurotoxic effects of feline immunodeficiency virus, FIV-PPR.

Gruol DL, Yu N, Parsons KL, Billaud JN, Elder JH, Phillips TR.

J Neurovirol. 1998 Aug;4(4):415-25.

PMID:
9718133
3.

Frontal lobe neuronal injury correlates to altered function in FIV-infected cats.

Podell M, Maruyama K, Smith M, Hayes KA, Buck WR, Ruehlmann DS, Mathes LE.

J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):10-8.

PMID:
10534142
4.

Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.

Sung YH, Cho SC, Hwang J, Kim SJ, Kim H, Bae S, Kim N, Chang KH, Daniels M, Renshaw PF, Lyoo IK.

Drug Alcohol Depend. 2007 Apr 17;88(1):28-35. Epub 2006 Nov 7.

PMID:
17084995
5.

Neuropathology in cats experimentally infected with feline immunodeficiency virus: a morphological, immunocytochemical and morphometric study.

Poli A, Abramo F, Di Iorio C, Cantile C, Carli MA, Pollera C, Vago L, Tosoni A, Costanzi G.

J Neurovirol. 1997 Oct;3(5):361-8.

PMID:
9372457
6.

In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain.

Ratai EM, Pilkenton SJ, Greco JB, Lentz MR, Bombardier JP, Turk KW, He J, Joo CG, Lee V, Westmoreland S, Halpern E, Lackner AA, González RG.

BMC Neurosci. 2009 Jun 22;10:63. doi: 10.1186/1471-2202-10-63.

7.

Effects of multiple acute morphine exposures on feline immunodeficiency virus disease progression.

Barr MC, Billaud JN, Selway DR, Huitron-Resendiz S, Osborn KG, Henriksen SJ, Phillips TR.

J Infect Dis. 2000 Sep;182(3):725-32. Epub 2000 Aug 14.

PMID:
10950765
8.

Neurobehavioral performance in feline immunodeficiency virus infection: integrated analysis of viral burden, neuroinflammation, and neuronal injury in cortex.

Maingat F, Vivithanaporn P, Zhu Y, Taylor A, Baker G, Pearson K, Power C.

J Neurosci. 2009 Jul 1;29(26):8429-37. doi: 10.1523/JNEUROSCI.5818-08.2009.

9.

Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3.

Huitron-Resendiz S, De Rozières S, Sanchez-Alavez M, Bühler B, Lin YC, Lerner DL, Henriksen NW, Burudi M, Fox HS, Torbett BE, Henriksen S, Elder JH.

J Virol. 2004 May;78(9):4525-32.

10.

Cytokine modulation of the innate immune response in feline immunodeficiency virus-infected cats.

Dean GA, LaVoy A, Yearley J, Stanton C.

J Infect Dis. 2006 Jun 1;193(11):1520-7. Epub 2006 Apr 26.

PMID:
16652280
11.

Neurovirulence depends on virus input titer in brain in feline immunodeficiency virus infection: evidence for activation of innate immunity and neuronal injury.

Johnston JB, Silva C, Hiebert T, Buist R, Dawood MR, Peeling J, Power C.

J Neurovirol. 2002 Oct;8(5):420-31.

PMID:
12402168
12.

Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.

Uncini Manganelli RE, Zaccaro L, Tomei PE.

J Ethnopharmacol. 2005 Apr 26;98(3):323-7.

PMID:
15814267
13.

Feline immunodeficiency virus dendritic cell infection and transfer.

Sprague WS, Robbiani M, Avery PR, O'Halloran KP, Hoover EA.

J Gen Virol. 2008 Mar;89(Pt 3):709-15. doi: 10.1099/vir.0.83068-0.

PMID:
18272762
14.

Escalating morphine exposures followed by withdrawal in feline immunodeficiency virus-infected cats: a model for HIV infection in chronic opiate abusers.

Barr MC, Huitron-Resendiz S, Sanchez-Alavez M, Henriksen SJ, Phillips TR.

Drug Alcohol Depend. 2003 Nov 24;72(2):141-9.

PMID:
14636969
15.

Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection.

Bucy DS, Brown MS, Bielefeldt-Ohmann H, Thompson J, Bachand AM, Morges M, Elder JH, Vandewoude S, Kraft SL.

J Neurovirol. 2011 Aug;17(4):341-52. doi: 10.1007/s13365-011-0040-7. Epub 2011 Jul 23.

16.

Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.

Dean GA, LaVoy A, Burkhard MJ.

Vet Immunol Immunopathol. 2004 Jul;100(1-2):49-59.

PMID:
15182995
17.

Decreased expression of MAP-2 and GAD in the brain of cats infected with feline immunodeficiency virus.

Koirala TR, Nakagaki K, Ishida T, Nonaka S, Morikawa S, Tabira T.

Tohoku J Exp Med. 2001 Nov;195(3):141-51.

18.

Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children.

Banakar S, Thomas MA, Deveikis A, Watzl JQ, Hayes J, Keller MA.

J Magn Reson Imaging. 2008 Apr;27(4):710-7. doi: 10.1002/jmri.21251.

PMID:
18383256
19.

HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection.

Coleman JK, Pu R, Martin M, Sato E, Yamamoto JK.

AIDS. 2005 Sep 23;19(14):1457-66.

PMID:
16135898

Supplemental Content

Support Center